Your browser doesn't support javascript.
loading
DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway.
Tong, Zhuting; Fang, Weiyang; Xu, Meng; Xia, YeYe; Wang, Rui; Li, Yue; Zha, Tianqi; Xiao, Liang; Pan, Shuhao; Chai, Huiping; Zhao, Lei; Wang, Hao; Pan, Huaguang; Chen, Xiangcun.
Afiliação
  • Tong Z; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. zhuting_tong@ahmu.edu.cn.
  • Fang W; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Xu M; Department of Electrocardiography, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Xia Y; Department of Oncology, Changhai Hospital, The Second Military Medical University, Shanghai, China.
  • Wang R; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Li Y; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Zha T; Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Sun Yat-Sen University, Guangzhou, China.
  • Xiao L; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Pan S; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Chai H; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Zhao L; Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Wang H; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Pan H; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Chen X; Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Cancer Cell Int ; 22(1): 106, 2022 Mar 05.
Article em En | MEDLINE | ID: mdl-35248066
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China